Nanosonics (ASX: NAN) has a poor short term outlook but the very high short interest may create a tasty opportunity down the track.

Nanosonics shares dropped this morning when it updated the market on its half year revenue, and its distribution agreement with GE Healthcare.

Claude Walker, Matt Joass, Andrew Page, and Kevin Fung discuss Nanosonics stock and the impact of omicron on investors.

The Nanosonics share price is up over 20% on results, thanks to a much stronger second half. So is it time to take profits?

In this video, I explain why I’m currently accumulating Nanosonics shares…

These 3 stocks remained profitable throughout the pandemic, are positioned for a stronger 2021, and are not too far from attractive value…

The Nanosonics share price dived today on a weak first half revenue result, but the future may look brighter.

The zeitgeist may shift in 2021…

Removing a few companies and adding 6 more…

It’s steady as she goes for Nanosonics in the 1st half of FY 2020, but that won’t be enough for an optimistic market…